BAL PHARMA
|
BAL PHARMA Last 5 Year Balance Sheet History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
EQUITY AND LIABILITIES | |||||
Share Capital | ₹16 Cr | ₹16 Cr | ₹15 Cr | ₹15 Cr | ₹14 Cr |
Equity - Authorised | ₹20 Cr | ₹20 Cr | ₹20 Cr | ₹20 Cr | ₹20 Cr |
Equity - Issued | ₹16 Cr | ₹16 Cr | ₹15 Cr | ₹15 Cr | ₹14 Cr |
Equity Paid Up | ₹16 Cr | ₹16 Cr | ₹15 Cr | ₹15 Cr | ₹14 Cr |
Equity Shares Forfeited | - | - | - | - | - |
Adjustments to Equity | - | - | - | - | - |
Preference Capital Paid Up | - | - | - | - | - |
Face Value | ₹10.00 | ₹10.00 | ₹10.00 | ₹10.00 | ₹10.00 |
Share Warrants & Outstandings | - | - | ₹0.94 Cr | ₹0.94 Cr | - |
Total Reserves | ₹53 Cr | ₹48 Cr | ₹43 Cr | ₹38 Cr | ₹38 Cr |
Securities Premium | ₹32 Cr | ₹32 Cr | ₹28 Cr | ₹27 Cr | ₹24 Cr |
Capital Reserves | ₹0.44 Cr | ₹0.44 Cr | ₹0.44 Cr | ₹0.44 Cr | ₹0.44 Cr |
Profit & Loss Account Balance | ₹19 Cr | ₹15 Cr | ₹14 Cr | ₹9.45 Cr | ₹13 Cr |
General Reserves | ₹2.45 Cr | ₹2.45 Cr | ₹2.45 Cr | ₹2.45 Cr | ₹2.45 Cr |
Other Reserves | ₹-0.61 Cr | ₹-0.97 Cr | ₹-1.20 Cr | ₹-1.20 Cr | ₹-1.30 Cr |
Reserve excluding Revaluation Reserve | ₹53 Cr | ₹48 Cr | ₹43 Cr | ₹38 Cr | ₹38 Cr |
Revaluation reserve | - | - | - | - | - |
Shareholder's Funds | ₹69 Cr | ₹64 Cr | ₹59 Cr | ₹54 Cr | ₹52 Cr |
Minority Interest | ₹-0.03 Cr | ₹-0.09 Cr | ₹-0.13 Cr | ₹-0.23 Cr | ₹-7.10 Cr |
Long-Term Borrowings | - | - | - | - | - |
Secured Loans | ₹24 Cr | ₹14 Cr | ₹27 Cr | ₹24 Cr | ₹23 Cr |
Non Convertible Debentures | - | - | - | - | - |
Converible Debentures & Bonds | - | - | - | - | - |
Packing Credit - Bank | - | - | - | - | - |
Inter Corporate & Security Deposit | - | - | - | - | - |
Term Loans - Banks | ₹11 Cr | ₹12 Cr | ₹12 Cr | ₹15 Cr | ₹12 Cr |
Term Loans - Institutions | - | - | - | - | - |
Other Secured | ₹13 Cr | ₹1.85 Cr | ₹15 Cr | ₹8.69 Cr | ₹11 Cr |
Unsecured Loans | ₹12 Cr | ₹16 Cr | - | - | ₹0.22 Cr |
Fixed Deposits - Public | - | - | - | - | - |
Loans and advances from subsidiaries | - | - | - | - | - |
Inter Corporate Deposits (Unsecured) | - | - | - | - | - |
Foreign Currency Convertible Notes | - | - | - | - | - |
Long Term Loan in Foreign Currency | - | - | - | - | - |
Loans - Banks | - | - | - | - | ₹0.12 Cr |
Loans - Govt. | - | - | - | - | - |
Loans - Others | ₹12 Cr | ₹16 Cr | - | - | - |
Other Unsecured Loan | - | - | - | - | ₹0.10 Cr |
Deferred Tax Assets / Liabilities | ₹1.55 Cr | ₹0.70 Cr | ₹0.60 Cr | ₹2.63 Cr | ₹3.58 Cr |
Deferred Tax Assets | ₹3.51 Cr | ₹4.89 Cr | ₹4.58 Cr | ₹4.51 Cr | ₹3.90 Cr |
Deferred Tax Liability | ₹5.06 Cr | ₹5.59 Cr | ₹5.18 Cr | ₹7.15 Cr | ₹7.49 Cr |
Other Long Term Liabilities | ₹1.83 Cr | ₹1.68 Cr | ₹4.08 Cr | ₹3.56 Cr | ₹3.21 Cr |
Long Term Trade Payables | - | - | - | - | - |
Long Term Provisions | ₹5.09 Cr | ₹5.07 Cr | ₹4.69 Cr | ₹4.07 Cr | ₹3.62 Cr |
Total Non-Current Liabilities | ₹45 Cr | ₹38 Cr | ₹36 Cr | ₹34 Cr | ₹34 Cr |
Current Liabilities | - | - | - | - | - |
Trade Payables | ₹77 Cr | ₹79 Cr | ₹66 Cr | ₹47 Cr | ₹39 Cr |
Sundry Creditors | ₹77 Cr | ₹79 Cr | ₹66 Cr | ₹47 Cr | ₹39 Cr |
Acceptances | - | - | - | - | - |
Due to Subsidiaries- Trade Payables | - | - | - | - | - |
Other Current Liabilities | ₹27 Cr | ₹31 Cr | ₹24 Cr | ₹24 Cr | ₹31 Cr |
Bank Overdraft / Short term credit | - | - | - | ₹1.30 Cr | ₹1.17 Cr |
Advances received from customers | ₹8.60 Cr | ₹12 Cr | ₹6.28 Cr | ₹5.97 Cr | ₹11 Cr |
Interest Accrued But Not Due | ₹0.16 Cr | ₹0.18 Cr | ₹0.47 Cr | ₹0.47 Cr | ₹0.14 Cr |
Share Application Money | - | - | - | - | - |
Current maturity of Debentures & Bonds | - | - | - | - | - |
Current maturity - Others | - | - | - | - | - |
Other Liabilities | ₹18 Cr | ₹18 Cr | ₹17 Cr | ₹16 Cr | ₹19 Cr |
Short Term Borrowings | ₹96 Cr | ₹93 Cr | ₹71 Cr | ₹81 Cr | ₹90 Cr |
Secured ST Loans repayable on Demands | ₹90 Cr | ₹87 Cr | ₹65 Cr | ₹75 Cr | ₹70 Cr |
Working Capital Loans- Sec | ₹89 Cr | ₹87 Cr | ₹65 Cr | ₹75 Cr | ₹66 Cr |
Buyers Credits - Unsec | - | - | - | - | - |
Commercial Borrowings- Unsec | - | - | - | - | - |
Other Unsecured Loans | ₹-84 Cr | ₹-81 Cr | ₹-59 Cr | ₹-69 Cr | ₹-47 Cr |
Short Term Provisions | ₹3.17 Cr | ₹6.64 Cr | ₹5.12 Cr | ₹0.98 Cr | ₹0.50 Cr |
Proposed Equity Dividend | - | - | - | - | - |
Provision for Corporate Dividend Tax | - | - | - | - | - |
Provision for Tax | ₹2.22 Cr | ₹6.01 Cr | ₹4.39 Cr | ₹0.32 Cr | - |
Provision for post retirement benefits | - | - | - | - | - |
Preference Dividend | - | - | - | - | - |
Other Provisions | ₹0.95 Cr | ₹0.64 Cr | ₹0.73 Cr | ₹0.66 Cr | ₹0.50 Cr |
Total Current Liabilities | ₹203 Cr | ₹209 Cr | ₹166 Cr | ₹153 Cr | ₹159 Cr |
Total Liabilities | ₹317 Cr | ₹311 Cr | ₹261 Cr | ₹240 Cr | ₹238 Cr |
ASSETS | |||||
Gross Block | ₹138 Cr | ₹127 Cr | ₹111 Cr | ₹105 Cr | ₹98 Cr |
Less: Accumulated Depreciation | ₹61 Cr | ₹51 Cr | ₹44 Cr | ₹37 Cr | ₹27 Cr |
Less: Impairment of Assets | - | - | - | - | - |
Net Block | ₹77 Cr | ₹76 Cr | ₹67 Cr | ₹69 Cr | ₹71 Cr |
Lease Adjustment A/c | - | - | - | - | - |
Capital Work in Progress | ₹0.47 Cr | - | ₹1.61 Cr | - | ₹3.32 Cr |
Non Current Investments | - | - | - | - | - |
Long Term Investment | - | - | - | - | - |
Quoted | ₹0.11 Cr | ₹0.11 Cr | ₹0.11 Cr | ₹0.11 Cr | - |
Unquoted | ₹0.02 Cr | ₹0.02 Cr | ₹0.02 Cr | ₹0.02 Cr | - |
Long Term Loans & Advances | ₹5.23 Cr | ₹4.61 Cr | ₹5.01 Cr | ₹4.86 Cr | ₹5.43 Cr |
Other Non Current Assets | ₹0.45 Cr | ₹1.78 Cr | ₹1.95 Cr | ₹2.49 Cr | ₹1.56 Cr |
Total Non-Current Assets | ₹83 Cr | ₹83 Cr | ₹76 Cr | ₹76 Cr | ₹81 Cr |
Current Assets Loans & Advances | - | - | - | - | - |
Currents Investments | ₹6.76 Cr | - | - | - | - |
Quoted | - | - | - | - | - |
Unquoted | ₹6.76 Cr | - | - | - | - |
Inventories | ₹88 Cr | ₹98 Cr | ₹74 Cr | ₹60 Cr | ₹68 Cr |
Raw Materials | ₹25 Cr | ₹36 Cr | ₹31 Cr | ₹23 Cr | ₹25 Cr |
Work-in Progress | ₹31 Cr | ₹27 Cr | ₹18 Cr | ₹12 Cr | ₹6.48 Cr |
Finished Goods | ₹26 Cr | ₹29 Cr | ₹20 Cr | ₹21 Cr | ₹32 Cr |
Packing Materials | ₹5.49 Cr | ₹5.36 Cr | ₹4.88 Cr | ₹4.16 Cr | ₹4.11 Cr |
Stores  and Spare | ₹0.07 Cr | ₹0.07 Cr | ₹0.05 Cr | ₹0.04 Cr | ₹0.13 Cr |
Other Inventory | - | - | - | - | - |
Sundry Debtors | ₹100 Cr | ₹94 Cr | ₹75 Cr | ₹67 Cr | ₹50 Cr |
Debtors more than Six months | ₹8.71 Cr | ₹16 Cr | ₹0.91 Cr | - | - |
Debtors Others | ₹93 Cr | ₹80 Cr | ₹75 Cr | ₹68 Cr | ₹50 Cr |
Cash and Bank | ₹13 Cr | ₹7.61 Cr | ₹5.39 Cr | ₹3.85 Cr | ₹3.13 Cr |
Cash in hand | ₹0.04 Cr | ₹0.03 Cr | ₹0.03 Cr | ₹0.20 Cr | ₹0.28 Cr |
Balances at Bank | ₹13 Cr | ₹7.58 Cr | ₹5.37 Cr | ₹3.65 Cr | ₹2.86 Cr |
Other cash and bank balances | - | - | - | - | - |
Other Current Assets | ₹4.58 Cr | ₹3.73 Cr | ₹12 Cr | ₹4.69 Cr | ₹4.07 Cr |
Interest accrued on Investments | - | - | - | - | - |
Interest accrued on Debentures | - | - | - | - | - |
Deposits with Government | - | - | - | - | - |
Interest accrued and or due on loans | - | - | ₹6.17 Cr | - | - |
Prepaid Expenses | ₹0.97 Cr | ₹0.72 Cr | ₹0.59 Cr | ₹0.08 Cr | ₹0.33 Cr |
Other current_assets | ₹3.61 Cr | ₹3.01 Cr | ₹5.74 Cr | ₹4.61 Cr | ₹3.74 Cr |
Short Term Loans and Advances | ₹22 Cr | ₹25 Cr | ₹17 Cr | ₹28 Cr | ₹33 Cr |
Advances recoverable in cash or in kind | ₹4.82 Cr | ₹6.30 Cr | ₹4.32 Cr | ₹9.42 Cr | ₹21 Cr |
Advance income tax and TDS | ₹0.12 Cr | ₹0.15 Cr | ₹0.10 Cr | ₹0.02 Cr | ₹0.11 Cr |
Amounts due from directors | - | - | - | - | - |
Due From Subsidiaries | - | - | - | - | - |
Inter corporate deposits | - | - | - | - | - |
Corporate Deposits | - | - | - | - | - |
Other Loans & Advances | ₹17 Cr | ₹18 Cr | ₹13 Cr | ₹19 Cr | ₹11 Cr |
Total Current Assets | ₹234 Cr | ₹228 Cr | ₹185 Cr | ₹164 Cr | ₹157 Cr |
Net Current Assets (Including Current Investments) | ₹31 Cr | ₹19 Cr | ₹19 Cr | ₹12 Cr | ₹-2.12 Cr |
Miscellaneous Expenses not written off | - | - | - | - | - |
Total Assets | ₹317 Cr | ₹311 Cr | ₹261 Cr | ₹240 Cr | ₹238 Cr |
Contingent Liabilities | ₹17 Cr | ₹16 Cr | ₹16 Cr | ₹13 Cr | ₹13 Cr |
Total Debt | ₹140 Cr | ₹131 Cr | ₹104 Cr | ₹110 Cr | ₹118 Cr |
Book Value | 43.84 | 40.66 | 38.92 | 35.52 | 36.99 |
Adjusted Book Value | 43.84 | 40.66 | 38.92 | 35.52 | 36.99 |
Compare Balance Sheet of peers of BAL PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
BAL PHARMA | ₹182.5 Cr | 3.4% | -8.8% | -13.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹420,699.0 Cr | 1.3% | -4.7% | 22.8% | Stock Analytics | |
DIVIS LABORATORIES | ₹162,584.0 Cr | 6.3% | 3.3% | 59.2% | Stock Analytics | |
CIPLA | ₹116,022.0 Cr | -0.7% | -3.3% | 2.1% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹102,463.0 Cr | 2.1% | -9.7% | -0.3% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹98,434.8 Cr | 2.1% | -2.8% | 26.4% | Stock Analytics |
BAL PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
BAL PHARMA | 3.4% |
-8.8% |
-13.1% |
SENSEX | 2% |
0.1% |
8.6% |
You may also like the below Video Courses